Patent Assignment
Reel/Frame 051136/0258
Change of Address
Recorded: 2019-11-26
Pages: 2
Assignor
LUMENA PHARMACEUTICALS LLC
Executed: 2019-11-26
Assignee
LUMENA PHARMACEUTICALS LLC
300 SHIRE WAY, LEXINGTON, MASSACHUSETTS, 02421
Covered Property
(1)
Bile Acid Recycling Inhibitors for Treatment of Hypercholemia and Cholestatic Liver Disease
Application:
16/031,889 →
Publication:
US 2019/0169217
Related Assignments
(5)
Other recorded transfers of the patent in this record — the chain of ownership.
Change of Name
May 30, 2019
From: LUMENA PHARMACEUTICALS, INC.
To: LUMENA PHARMACEUTICALS LLC
Reel/Frame 051169/0574 →
Assignment of Assignor's Interest
May 30, 2019
From: GEDULIN, BRONISLAVA; GREY, MICHAEL; O'DONNELL, NIALL
To: LUMENA PHARMACEUTICALS, INC.
Reel/Frame 049323/0942 →
Merger and Change of Name
Sep 2, 2020
From: LUMENA PHARMACEUTICALS LLC; SHIRE HUMAN GENETIC THERAPIES, INC.
To: SHIRE HUMAN GENETIC THERAPIES, INC.
Reel/Frame 053670/0014 →
Security Interest
Dec 9, 2020
From: MIRUM PHARMACEUTICALS, INC.
To: MULHOLLAND SA LLC
Reel/Frame 054598/0910 →
Release of Security Interest
Apr 20, 2023
From: MULHOLLAND SA LLC
To: MIRUM PHARMACEUTICALS, INC.
Reel/Frame 063383/0795 →